Short term coseasonal sublingual immunotherapy reduced the development of asthma in children with hay feverCoseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis.

Novembre E, Galli E, Landi F, et al. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 2004; 114: 851–7.NovembreEGalliELandiFet alCoseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis.J Allergy Clin Immunol2004114851-7Q In children with allergic rhinoconjunctivitis (hay fever), does short term coseasonal sublingual immunotherapy reduce the development of asthma and seasonal hay fever symptoms?

For correspondence: Dr S E Burastero, San Raffaele Scientific Institute, Milano, Italy. [email protected]

Source of funding: no external funding.